Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:05 pm Unchanged | 2023-12-31 | 13G | AMBRX BIOPHARMA INC AMAM | Commodore Capital LP | 0 0.000% | 0 (Unchanged) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | CABALETTA BIO INC CABA | Commodore Capital LP | 1,900,000 4.400% | 441,633 (+30.28%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | CELCUITY INC CELC | Commodore Capital LP | 2,492,886 9.900% | 235,474 (+10.43%) | Filing History |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Commodore Capital LP | 700,000 2.300% | -185,741 (-20.97%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | SPYRE THERAPEUTICS, INC SYRE | Commodore Capital LP | 1,934,084 5.400% | 100,000 (+5.45%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | ENLIVEN THERAPEUTICS INC ELVN | Commodore Capital LP | 2,901,816 7.000% | 819,693 (+39.37%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | MERUS N V COM MRUS | Commodore Capital LP | 4,747,373 8.200% | 2,014,806 (+73.73%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-12-31 | 13G | SAB BIOTHERAPEUTICS INC NE SABS | Commodore Capital LP | 1,831,746 3.500% | 1,138,500 (+164.23%) | Filing History |
| 2024-02-14 4:05 pm Sale | 2023-12-31 | 13G | VIRIDIAN THERAPEUTICS INC VRDN | Commodore Capital LP | 1,924,074 3.700% | -96,092 (-4.76%) | Filing History |
| 2024-02-14 4:05 pm Purchase | 2023-06-14 | 13G | VERA THERAPEUTICS INC VERA | Commodore Capital LP | 5,001,783 11.300% | 2,658,926 (+113.49%) | Filing History |
| 2024-01-19 4:05 pm Purchase | 2024-01-10 | 13G | ADICET BIO INC ACET | Commodore Capital LP | 265,625 9.800% | 265,625 (New Position) | Filing History |
| 2023-12-22 4:05 pm Purchase | 2023-12-14 | 13G | C4 THERAPEUTICS INC CCCC | Commodore Capital LP | 3,800,000 7.700% | 3,800,000 (New Position) | Filing History |
| 2023-12-01 4:15 pm Purchase | 2023-11-24 | 13G | SPYRE THERAPEUTICS, INC SYRE | Commodore Capital LP | 1,834,084 6.100% | 1,834,084 (New Position) | Filing History |
| 2023-11-03 4:05 pm Purchase | 2023-10-25 | 13G | HARPOON THERAPEUTICS INC N HARP | Commodore Capital LP | 1,703,465 9.900% | 1,703,465 (New Position) | Filing History |
| 2023-10-27 4:05 pm Purchase | 2023-10-19 | 13G | NKARTA INC NKTX | Commodore Capital LP | 2,730,000 5.600% | 2,730,000 (New Position) | Filing History |
| 2023-10-16 4:05 pm Purchase | 2023-10-04 | 13G | SAB BIOTHERAPEUTICS INC SABS | Commodore Capital LP | 693,246 9.900% | 693,246 (New Position) | Filing History |
| 2023-10-12 4:05 pm Purchase | 2023-10-02 | 13G | SOLENO THERAPEUTICS INC PA SLNO | Commodore Capital LP | 885,741 6.000% | 885,741 (New Position) | Filing History |
| 2023-10-06 4:05 pm Purchase | 2023-10-04 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Commodore Capital LP | 2,367,884 9.900% | 792,884 (+50.34%) | Filing History |
| 2023-08-09 4:15 pm Purchase | 2023-08-07 | 13G | VISTAGEN THERAPEUTICS INC VTGN | Commodore Capital LP | 1,575,000 19.700% | 1,575,000 (New Position) | Filing History |
| 2023-04-27 4:05 pm Sale | 2023-04-24 | 13G | AMBRX BIOPHARMA INC SPONSORED AMAM | Commodore Capital LP | 31,181,983 8.100% | -4,518,017 (-12.66%) | Filing History |